Timo Veromaa

 MD, PhD, Board member

Herantis board member since 2012, Dr. Veromaa is the Executive Chairman of Domainex Ltd. He was the CEO and President of Biotie Therapies Corp. from 2005 until its acquisition by Acorda Therapeutics in 2016. During his earlier career he has been e.g. Medical Director of Schering Ltd. in Finland, Senior Scientist and Project Director of Collagen Corp. and Postdoctoral Fellow at Stanford University. Dr. Veromaa has a PhD in immunology from the University of Turku and as a MD holds a Special Competence in Pharmaceutical Medicine.